Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride and Flutamide in Recurrent Prostate Cancer
NCT00003323Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 1998
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finasteride, flutamide in prostate cancer (PCa), sponsored by Cancer and Leukemia Group B. Started May 1998; status: completed.
02
Drugs
finasterideflutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003323.